Solriamfetol-based Solutions for Optimizing Resource Efficiency and Enhancing Durability

Publication ID: 24-11857528_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Solriamfetol-based Solutions for Optimizing Resource Efficiency and Enhancing Durability,” Published Technical Disclosure No. 24-11857528_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857528_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,528.

Summary of the Inventive Concept

The inventive concept leverages the core technology of solriamfetol therapy to develop novel solutions for optimizing resource efficiency and enhancing durability in various industries, including agriculture, water treatment, renewable energy, and construction.

Background and Problem Solved

The original patent focuses on methods for decreasing adverse effects associated with solriamfetol therapy in subjects with impaired renal function. However, this invention has limitations in terms of its application scope. The new inventive concept addresses the problem of resource inefficiency and environmental degradation in various industries, where solriamfetol's properties can be utilized to create innovative solutions.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of applications, including: (1) a system for optimizing crop yields in agricultural fields with impaired soil function, where solriamfetol is administered to enhance plant growth and resistance to environmental stressors; (2) a method for reducing water consumption in industrial processes, where solriamfetol decreases the energy required for water treatment and reuse; (3) a system for treating wastewater, where solriamfetol breaks down organic pollutants and increases the efficiency of wastewater treatment processes; (4) a method for improving the efficiency of renewable energy systems, where solriamfetol enhances energy storage and release; and (5) a system for enhancing the durability of building materials, where solriamfetol increases their resistance to environmental degradation. These applications capitalize on solriamfetol's unique properties to create innovative solutions for resource efficiency and durability.

Novelty and Inventive Step

The new claims introduce a novel and non-obvious application of solriamfetol's core technology to entirely different industries, which was not originally considered. The inventive step lies in the recognition of solriamfetol's potential to address resource inefficiency and environmental degradation in these industries, and the development of innovative solutions that leverage its properties.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of solriamfetol in combination with other compounds or technologies to enhance its effects, or the development of new formulations or delivery methods for solriamfetol. Variations of the inventive concept could also include its application to other industries or fields, such as textiles, manufacturing, or aerospace.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, water treatment, renewable energy, and construction. The market for these solutions is substantial, with potential customers including farmers, industrial process operators, renewable energy providers, and construction companies. The inventive concept's ability to optimize resource efficiency and enhance durability could lead to significant cost savings, improved environmental sustainability, and increased competitiveness for companies that adopt these solutions.

Field of Art

Pharmaceutical and chemical engineering, with expertise in drug delivery systems, pharmacokinetics, and therapeutic applications across multiple domains

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in pharmaceutical sciences or chemical engineering, capable of understanding drug mechanism of action, exploring novel applications, and recognizing potential cross-industry technological adaptations

Obviousness Rationale

A PHOSITA would recognize that solriamfetol's core molecular properties and therapeutic mechanisms suggest potential broader applications beyond renal-impaired patient treatment. The published technical disclosure demonstrates predictable extensions of the compound's fundamental characteristics by applying its known biochemical interactions to solve resource efficiency challenges across different technical domains.

Obvious Combinations & Variations

Source Patent Element
Solriamfetol's ability to modulate physiological responses in impaired biological systems
PTD Variation
Applying solriamfetol to enhance plant growth in agricultural fields with impaired soil function
Obviousness Reasoning
A PHOSITA would recognize that the compound's mechanism for addressing systemic impairment could be analogously applied to plant biological systems, representing a predictable technological transfer
Source Patent Element
Precise dosage control and targeted administration demonstrated in original patent
PTD Variation
Controlled administration of solriamfetol in industrial water treatment processes
Obviousness Reasoning
The source patent's emphasis on precise pharmaceutical delivery suggests obvious adaptability to controlled industrial chemical interventions
Source Patent Element
Understanding solriamfetol's molecular interaction capabilities
PTD Variation
Using solriamfetol to break down organic pollutants in wastewater treatment
Obviousness Reasoning
A PHOSITA would recognize the compound's potential for molecular interactions as a transferable capability across different chemical environments
Source Patent Element
Solriamfetol's energy modulation properties in biological systems
PTD Variation
Enhancing energy storage and release in renewable energy systems
Obviousness Reasoning
The compound's demonstrated ability to modulate energy-related processes suggests an obvious extension to alternative technological domains
Source Patent Element
Therapeutic compound designed to interact with complex systemic environments
PTD Variation
Incorporating solriamfetol to increase building material durability
Obviousness Reasoning
A PHOSITA would recognize the potential for molecular interactions to provide structural enhancement as a predictable technological adaptation
35 U.S.C. § 103 Summary: Based on US Patent 11857528's disclosure of solriamfetol's fundamental molecular properties and therapeutic mechanisms, the present published technical disclosure demonstrates that the claimed variations represent obvious technological extensions readily apparent to a person having ordinary skill in the art, thereby establishing robust prior art against potential future patent claims covering similar cross-domain applications of the compound.

Original Patent Information

Patent NumberUS 11,857,528
TitleMethods of providing solriamfetol therapy to subjects with impaired renal function
Assignee(s)AXSOME MALTA LTD.